| PC | Pulmonary Carcinoid |
| TC | Typical Carcinoid |
| AC | Atypical Carcinoid |
| CT | Computed tomography |
| MEN1 | Multiple endocrine neoplasia type 1 |
| SCLC | Small cell lung cancer |
| LCNEC | Large cell neuroendocrine carcinoma |
| 5-HIAA | 5-hydroxyindoleacetic acid |
| ACTH | adrenocorticotropic hormone |
| SIADH | syndrome of inappropriate antidiuretic hormone secretion |
| DIPNECH | Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia |
| PRRT | peptide receptor radionuclide therapy |
| SRS | somatostatin receptor scintigraphy |
| SPECT | single-photon emission computed tomography |
| FDG-PET | Positron emission tomography with fludeoxyglucose |
| EBUS-FNA | endobronchial ultrasound-guided fine-needle aspiration |
| EUS | endoscopic ultrasound |
| DOTA | Gallium-68-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
| TAE | transarterial embolization |
| TACE | transarterial chemoembolization |
| SSA | Somatostatin analogue |
| VEGF | Vascular endothelial growth factor |
| PDGFR | platelet-derived growth factor receptors |
| EGF | epidermal growth factor |
| SNP | single nucleotide polymorphism |